本页面由Tiger Trade Technology Pte. Ltd.提供服务

再生元制药公司

750.57
+4.570.61%
盘后750.570.00000.00%19:36 EDT
成交量:51.30万
成交额:3.85亿
市值:793.50亿
市盈率:18.05
高:758.61
开:754.74
低:746.91
收:746.00
52周最高:821.11
52周最低:476.49
股本:1.06亿
流通股本:1.03亿
量比:0.80
换手率:0.50%
股息:3.52
股息率:0.47%
每股收益(TTM):41.59
每股收益(LYR):41.48
净资产收益率:14.87%
总资产收益率:5.91%
市净率:2.54
市盈率(LYR):18.09

数据加载中...

2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/08

重要事件披露

Form 8-K - Current report
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/21

SEC问询函

Form CORRESP - Correspondence
2024/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities